Abbott's return welcomed by Australian industry
This article was originally published in Clinica
John Howard's election victory brought with it the return to the Australian Health and Ageing portfolio of Minister Tony Abbott. This was welcomed by local medtech industry participants, who have become familiar with the minister's style. His continuation in office is seen as a clear plus for the sector, says the Medical Industry Association of Australia (MIAA). New at the ministry is Christopher Pyne, as parliamentary secretary to the minister, who will have responsibilities covering the forthcoming joint trans Tasman regulatory agency.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.